Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet (2014-02569, 2014-07606, KAW 2020.0182, KAW 2020.0241)
- Knut and Alice Wallenberg Foundation (2014-02569, 2014-07606, KAW 2020.0182, KAW 2020.0241)
This publication has 26 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney InjuryScientific Reports, 2018
- Lung–Kidney Cross-Talk in the Critically Ill PatientAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Inflammasomes: mechanism of assembly, regulation and signallingNature Reviews Immunology, 2016
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent ScalabilityPLOS ONE, 2014
- Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit*Critical Care Medicine, 2011
- Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKIRenal Failure, 2010
- Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1Journal of Biological Chemistry, 2008
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admissionIntensive Care Medicine, 2005
- Elimination of cytokines by the kidney: comparison between normal individuals and patients with severe sepsis or the systemic inflammatory response syndromeBritish Journal of Anaesthesia, 2000